No common practice agreement can effectively cover any clinical situation. Therefore, the collaborative practice agreement should not and should not replace the exercise of professional judgment by nurse`s Practitioner. There are situations that concern patient care, both frequent and unusual, that require the individual exercise of the clinical judgment of the Practitioner De Nurse. Under the new rules, how will you deal with the prescription and dispensing of drugs and products that are not included in the Common Practice Agreement under Rule 21 NVC36.0809(b)(3)(A)(B) and 21 NVC32M.0109(b)(3)(A)(B)? This is not a complete list of questions or statements that should be considered for your collaborative practice agreement, but to guide your development of the collaborative practice agreement for your practice. As rules, 21NCAC36.0810 (b) (1) (2) and 21 NCAC32M.0110 (b) (1) (2) “Quality Assurance Standards for a Collaborative Practice Agreement”, the collaborative practice agreement is concluded and signed by the primary physician and the sole agent and maintained at any practice site. What medications, devices, medical treatments, tests and procedures that can be prescribed, ordered and performed could be adapted to the diagnosis and treatment of the most common medical problems in your nursing offices? What are your minimum standards for consultation between you as a nurse and your primary physician, as in 21 NVC 36.0810 (1) (A) -(B) (2) (3) (A) (C) and 21 NVC 32M (e) (1) (A) -B)) (2) (3) (A) –C)? This Nurse Practitioner/Physician consultation is different for the new graduate, the new Practitioner Nurse with the first admission to practice in North Carolina compared to a collaborative practice agreement between a nurse Practitioner previously admitted to the practice in North Carolina and another senior physician on call. How is patient counselling and transfer carried out in your practice? What medications and devices will you prescribe at each training ground? You can list by certain medications or categories of drugs. A detailed description of the categories of drugs and equipment to treat the most common health problems in your particular practice can be developed. For example: categories of drugs such as anti-Semites, oral hypoglycemic drugs/insulin, oral hormones and contraceptives, cephalosporins, aminoglycoids, antivirals, antiasthmatics, diuretics, antihypertensives, etc. may be indicated. Exceptions may be prescribed according to classes of drugs or certain drugs in a class or routes of administration.
A nurse practitioner could use one combination of the above approach or another to describe in the collaborative practice agreement the prescribing power of the Nurse Practitioner. It is necessary to describe in the Collaborative Practice Agreement the drugs and equipment that may be prescribed by the Practitioner Nurse at any practice site, as described in Rule 21 CVC32M.0109 “Prescribing Authority” and in Board of Nursing Rule 21 NCAC36.0809 “Prescribing Authority”. What will be your process, developed by the nurse and primary caregiver for ongoing verification of care at each practice site, including a written plan for assessing the quality of care for one or more common clinical issues? North Carolina Board of Nursing Board of Nursing 21 NCAC36.0800 “Approval and Practice Parameters for Nurse Practitioners” and the analogous rule of medical board 21 NCAC32M.0100 “Approval of Nurse Practers” came into force on August 1, 2004. . .